Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3Recruiting 2Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 1Endocrine 1

Conditions

Breast Neoplasms 1911Neoplasms 1531Prostatic Neoplasms 753Colorectal Neoplasms 714Lung Neoplasms 583Motor Activity 393Head and Neck Neoplasms 328Colonic Neoplasms 312Uterine Cervical Neoplasms 300Pain 248Pancreatic Neoplasms 246Anxiety Disorders 221Rectal Neoplasms 214Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 194Stomach Neoplasms 192Polycystic Ovary Syndrome 188Ovarian Neoplasms 186Precursor Cell Lymphoblastic Leukemia-Lymphoma 178Brain Neoplasms 169Depression 166Urinary Bladder Neoplasms 165Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 138Lymphoma 136Lymphoma, Follicular 128Obesity 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Completed × Non-alcoholic Fatty Liver Disease × Clear all
NCT07146815 2025-08-28

P-CORIGA

Ziekenhuis Oost-Limburg

Phase NA Completed
157 enrolled

Polycystic Ovary Syndrome, Non-alcoholic Fatty Liver Disease

NCT04186260 2025-08-24

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

University of Arizona

Phase NA Completed
15 enrolled
EndocrineOther

Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1, Overweight, Non-alcoholic Fatty Liver Disease

NCT02568787 2017-06-14

The Effect of an RBAC Supplement (BRM4) on NAFLD

University of Miami

Phase NA Completed
23 enrolled

Non-alcoholic Fatty Liver Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡